News

< Back

Grantee in the News: NY Times features Kenneth Langa on New Test for Early Dementia Detection

On July 24th, The New York Times featured comments by 2003 Beeson Scholar Kenneth Lango, MD, PhD, on a new questionnaire developed to help detect early signs of dementia.

Researchers believe that lasting personality change may be associated with dementia. Studies have found that patients with mild cognitive decline and signs of significant personality or mood change have a greater chance of developing dementia then patients who exhibit cognitive decline without personality change.

Assessing this questionnaire developed to potentially help doctors identify early onset of dementia through personality change, Dr. Lango warns that while this method may led to early detection, it could also result in overdiagnosis. He states, “There’s the potential benefit of early diagnosis, identifying people more likely to decline, the flip side is overdiagnosis, labeling someone and getting people in the clinical cascade, where you start doing the test and people start doing more brain imaging and being at the doctor’s more and getting more concerned.”

Dr. Langa, who also cites the economic costs of overdiagnosis, recommends that this test continue to be tested in a research setting before entering clinical practice.

Kenneth Lango, MD, PhD, is a Professor Internal Medicine, Gerontology, and Health Management and Policy at the University of Michigan.

Learn more about the symptoms of Alzheimer’s disease and dementia in our InfoAging portal.

More Recent News

View All News >
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Grantee in the News: Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Grantee in the News:  Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President